Europe Genome Editing Market to Grow at a CAGR of 18.2% to reach US$ 4,791.46 million from 2021 to 2028

Europe Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)

Report Date : Mar 2022
Report Code : TIPRE00003908

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 138

The genome editing market in Europe is expected to grow from US$ 1,487.30 million in 2021 to US$ 4,791.46 million by 2028; it is estimated to grow at a CAGR of 18.2% from 2021 to 2028.

Over the past few years, advances in genome editing technologies have been making constant headlines. Genome editing technologies can alter biological research and significantly impact human health, food security, and environmental sustainability since they are precise, relatively inexpensive, easy to use, and remarkably powerful. The advances in genome editing can be traced back to quiet beginnings in the 1990s. The introduction of CRISPR-Cas9—a genome-editing tool that can be used to make precise and targeted changes in the DNA sequence with ease—is mainly responsible for the recent rise in the amount and scope of applications of genome editing technologies. The CRISPR platform's ease of use, as compared to previous technologies, has resulted in its widespread adoption and application. Genome editing could have a favorable impact on sustainable development, environmental management, food security, and the introduction of affordable diagnostics and therapies for various diseases due to these advancements. Recognizing the potential of genome editing techniques for studying and manipulating the genome, the DBT has been fostering research and innovation in genome engineering technologies and applications to make them more accessible and inexpensive for research and development (R & R&D). Through focused calls for proposals in different areas such as the development of new methods, tools, processes, and platforms for genome editing, improvement of existing genome-editing methods, and novel applications of genome editing technologies in agriculture, bioenergy, environmental research, and human health, efforts have been made to encourage R&D programs in emerging genome engineering technologies and their applications. Despite contributing to one-third of all deaths worldwide, there is no effective treatment, to date, for fibrosis. This study has established PAI-1 as a novel drug target, and pharmacologically targeting this protein may be an effective treatment for combating fibrosis. These factors for CRISPR system research are likely to favor the market's growth.

Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. The cell therapy instruments supply chain, which is already logistically complicated, has to face new challenges. The cell therapy instrument market has also witness some shortfall at the beginning of COVID 19 crisis owing to factors such as disruption in supply chain and demand due to lock down announced by majority of European countries. For instance, in July 2020 the UK government has allotted 100 million Euros funds to the Cell and Gene Therapy Catapult Manufacturing Innovation Centre to expedite the production of a vaccine for COVID-19 in the UK. Moreover, Stempeutics Research has filed application seeking European Commission Funding to develop cell therapy for COVID 19. The company has also entered into partnership with global consortium of cell therapy companies to gather funding for cell therapy research from European commission. Hence, Europe market is likely to show significant growth prospects during this pandemic and forecasted year.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe genome editing market. The Europe genome editing market is expected to grow at a good CAGR during the forecast period.

Europe Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Inquire for Discount

Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Request discounts available for Start-Ups & Universities

Europe Genome Editing Market Segmentation

Europe Genome Editing Market – By Technology

CRISPR
TALEN
Antisense
Other

Europe Genome Editing Market – By Application

Cell Line Engineering
Genetic Engineering
Diagnostic Applications
Drug Discovery
Others

Europe Genome Editing Market – By End User

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Clinical Research Organizations (CRO's)

Europe Genome Editing Market – By Country

Germany
UK
France
Italy
Spain
Rest of Europe

Europe Genome Editing Market – Companies Mentioned

THERMO FISHER SCIENTIFIC INC.
MERCK KGaA
Lonza
Horizon Discovery Group plc.
Integrated DNA Technologies
GenScript
New England Biolabs
Eurofins Scientific
CRISPR Therapeutics

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Technology, and Country

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

UK, Germany, France, Italy, Russia

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Genome Editing Market– By Technology

1.3.2 Europe Genome Editing Market– By Application

1.3.3 Europe Genome Editing Market– By End User

1.3.4 Europe Genome Editing Market– By Country

2. Europe Genome Editing Market– Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Genome Editing Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinion

5. Europe Genome EditingMarket – Key Market Dynamics

5.1 Market Drivers

5.1.1 Burgeoning Prevalence of Cancer and Other Genetic Disorders

5.1.2 Progressive Technological Advancements in Gene-Editing Tools

5.2 Market Restraints

5.2.1 Expensive Cost of Genomic Equipment

5.3 Future Trends

5.3.1 Growing Technological Innovations

5.4 Impact Analysis

6. Europe Genome Editing Market Analysis

6.1 Europe Genome Editing Market Revenue Forecast and Analysis

7. Europe Genome Editing Market Revenue and Forecasts to 2028– by Technology

7.1 Overview

7.2 Europe Genome Editing Market, By Technology, 2021 & 2028 (%)

7.3 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

7.3.1 Overview

7.3.2 CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.4 TALEN

7.4.1 Overview

7.4.2 TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.5 Antisense

7.5.1 Overview

7.5.2 Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Genome Editing Market Revenue and Forecasts to 2028 – Application

8.1 Overview

8.2 Europe Genome Editing Market Share, By Application - 2021 & 2028 (%)

8.3 Cell Line Engineering

8.3.1 Overview

8.3.2 Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Genetic Engineering

8.4.1 Overview

8.4.2 Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.5 Diagnostic Applications

8.5.1 Overview

8.5.2 Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.6 Drug Discovery

8.6.1 Overview

8.6.2 Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Genome Editing Market Revenue and Forecasts to 2028 – End User

9.1 Overview

9.2 Europe Genome Editing Market Share by End User - 2021 & 2028 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.4 Clinical Research Organizations (CRO’s)

9.4.1 Overview

9.4.2 Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Genome Editing Market – Country Analysis

10.1 Overview

10.1.1 Europe: Genome Editing Market, by Country, 2021 & 2028 (%)

10.1.1.1 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4 Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.5 Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.5 France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5 UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4 Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5 Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4 Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5 Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4 Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5 Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Europe Genome Editing Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Europe Genome Editing Market– Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 MERCK KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Lonza

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Horizon Discovery Group plc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Integrated DNA Technologies

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 GenScript

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 New England Biolabs

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Eurofins Scientific

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 CRISPR Therapeutics

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 Glossary of Terms

LIST OF TABLES

Table 1. Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2. Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 3. Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 4. France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 5. France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 6. France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 8. UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 9. UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10. Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 11. Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 12. Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13. Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 14. Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 15. Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 17. Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19. Organic Developments Done by Companies

Table 20. Inorganic Developments Done by Companies

Table 21. Glossary of Terms, Europe Genome Editing Market

LIST OF FIGURES

Figure 1. Europe Genome Editing Market Segmentation

Figure 2. Europe Genome Editing Market Segmentation, By Country

Figure 3. Europe Genome Editing Market Overview

Figure 4. CRISPR Held Largest Share of Technology Segment in Europe Genome Editing Market

Figure 5. Germany to Show Remarkable Growth During Forecast Period

Figure 6. Europe Genome Editing Market, Industry Landscape

Figure 7. Europe: PEST Analysis

Figure 8. Expert Opinion

Figure 9. Europe Genome Editing Market Impact Analysis of Drivers and Restraints

Figure 10. Europe Genome Editing Market– Revenue Forecast and Analysis – 2021-2028

Figure 11. Europe Genome Editing Market, by Technology, 2021 & 2028 (%)

Figure 12. CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 15. Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 16. Europe Genome Editing Market Share, by Application - 2021 & 2028 (%)

Figure 17. Cell Line Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Genetic Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Diagnostic Applications: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Drug Discovery: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Others: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Europe Genome Editing Market Share by End User - 2021 & 2028 (%)

Figure 23. Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Clinical Research Organizations: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Academic and Research Institutes: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Europe: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)

Figure 27. Europe: Genome Editing Market, by Country, 2021 & 2028 (%)

Figure 28. Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Impact of COVID-19 Pandemic in European Country Markets

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.